Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
Anti-Cancer Drugs|September 23, 2003
Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy StudyM S Stratton, M E Reid, G Schwartzberg, et al.
British Journal of Haematology|August 1, 1994
Transient loss of proteins carrying Kell and Lutheran red cell antigens during consecutive relapses of autoimmune thrombocytopeniaL M Williamson, J Poole, C Redman, et al.
Anti-Cancer Drugs|September 23, 2003
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' StudyM S Stratton, M E Reid, G Schwartzberg, et al.
Transfusion|May 26, 2004
RH locus contraction in a novel Dc-/D-- genotype resulting from separate genetic recombination eventsC-H Huang, J Peng, H C Chen, et al.
Vox Sanguinis|January 1, 1995
Expression of the erythrocyte antigen Henshaw (He; MNS6): serological and immunochemical studiesM E Reid, C Lomas-Francis, G L Daniels, et al.
Vox Sanguinis|January 1, 1986
A family demonstrating inheritance of the Leach phenotype: a Gerbich-negative phenotype associated with elliptocytosisG L Daniels, M A Shaw, P A Judson, et al.
Cancer Research|October 28, 1999
Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomasM E Martínez, T Maltzman, J R Marshall, et al.
BJU International|April 18, 2003
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer TrialA J Duffield-Lillico, B L Dalkin, M E Reid, et al.
Blood|August 15, 1994
Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypesD M Lublin, G Mallinson, J Poole, et al.
Immunohematology|February 21, 2008
An alloantibody to a high-prevalence MNS antigen in a person with a GP.JL/Mk phenotypeJ Ratliff, S Veneman, J Ward, et al.
Pageof 24